CYTO365
Höganäs
About CYTO365
CYTO365 is the manufacturer of RondelO multi inlet stopcock, which is sold as a component aimed to be integrated into IV-set to combat Drug Incompatibility due to parallel infusion.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.9M
- Funding stage: Seed
- Last round: Seed (Dec 2022)
- Website: cyto365.com
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cyto365-146055 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.